AKER - Akers Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPSN/A-15.36N/AN/A
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts0010
Avg. EstimateN/AN/A11MN/A
Low EstimateN/AN/A11MN/A
High EstimateN/AN/A11MN/A
Year Ago SalesN/AN/A3.93M11M
Sales Growth (year/est)N/AN/A179.90%N/A
Earnings HistoryInvalid Date6/29/20179/29/201712/30/2017
EPS Est.N/A-7.68011.52
EPS ActualN/A-15.36-24.96-38.4
DifferenceN/A-7.68-24.96-49.92
Surprise %N/A-100.00%N/A-433.30%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate0000
7 Days Ago000.140
30 Days Ago000.140
60 Days Ago000.140
90 Days Ago000.140
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesAKERIndustrySectorS&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/A0.08
Current YearN/AN/AN/A0.01
Next YearN/AN/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A